{"transactions":[{"id":691386,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2026-08-11T20:39:29.000Z","date":"2026-08-10","kind":"other","planned":false,"acquired":true,"shares":9908,"price":50.46,"value":499957.68,"ownership":{"direct":false,"nature":"By 401(k)"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquistion made pursuant to an election by the reporting person to rebalance their holdings under the Company's 401(k) Retirement Savings Plan, which resulted in a discretionary transaction in shares of the Company's common stock."}],"balance_after":9908,"source":{"system":"sec-edgar","filing":"0001225208-26-007062","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826007062/doc4.xml","form_type":"4"}},{"id":719763,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Restricted Stock Units","published_at":"2026-07-02T20:07:11.000Z","date":"2026-07-01","kind":"exercise","planned":false,"acquired":false,"shares":2087,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2026, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2026, the first anniversary of the date of grant."}],"balance_after":6263,"derivative":{"expiration_date":"2029-07-01","underlying":"Common Stock","underlying_shares":2087},"source":{"system":"sec-edgar","filing":"0001225208-26-006362","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826006362/doc4.xml","form_type":"4"}},{"id":719762,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2026-07-02T20:07:11.000Z","date":"2026-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1010,"price":43.06,"value":43490.6,"ownership":{"direct":true},"balance_after":39063,"source":{"system":"sec-edgar","filing":"0001225208-26-006362","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826006362/doc4.xml","form_type":"4"}},{"id":719761,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2026-07-02T20:07:11.000Z","date":"2026-07-01","kind":"exercise","planned":false,"acquired":true,"shares":2087,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":40073,"source":{"system":"sec-edgar","filing":"0001225208-26-006362","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826006362/doc4.xml","form_type":"4"}},{"id":898692,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Restricted Stock Units","published_at":"2026-02-18T22:58:53.000Z","date":"2026-02-16","kind":"exercise","planned":false,"acquired":false,"shares":990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"expiration_date":"2026-02-16","underlying":"Common Stock","underlying_shares":990},"source":{"system":"sec-edgar","filing":"0001225208-26-002136","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002136/doc4.xml","form_type":"4"}},{"id":898691,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Restricted Stock Units","published_at":"2026-02-18T22:58:53.000Z","date":"2026-02-14","kind":"exercise","planned":false,"acquired":false,"shares":1058,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant."}],"balance_after":1058,"derivative":{"expiration_date":"2027-02-14","underlying":"Common Stock","underlying_shares":1058},"source":{"system":"sec-edgar","filing":"0001225208-26-002136","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002136/doc4.xml","form_type":"4"}},{"id":898690,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Restricted Stock Units","published_at":"2026-02-18T22:58:53.000Z","date":"2026-02-13","kind":"exercise","planned":false,"acquired":false,"shares":1766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant."}],"balance_after":5300,"derivative":{"expiration_date":"2029-02-13","underlying":"Common Stock","underlying_shares":1766},"source":{"system":"sec-edgar","filing":"0001225208-26-002136","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002136/doc4.xml","form_type":"4"}},{"id":898689,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2026-02-18T22:58:53.000Z","date":"2026-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":440,"price":74.73,"value":32881.2,"ownership":{"direct":true},"balance_after":37986,"source":{"system":"sec-edgar","filing":"0001225208-26-002136","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002136/doc4.xml","form_type":"4"}},{"id":898688,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2026-02-18T22:58:53.000Z","date":"2026-02-16","kind":"exercise","planned":false,"acquired":true,"shares":990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":38426,"source":{"system":"sec-edgar","filing":"0001225208-26-002136","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002136/doc4.xml","form_type":"4"}},{"id":898687,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2026-02-18T22:58:53.000Z","date":"2026-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":470,"price":74.73,"value":35123.1,"ownership":{"direct":true},"balance_after":37436,"source":{"system":"sec-edgar","filing":"0001225208-26-002136","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002136/doc4.xml","form_type":"4"}},{"id":898686,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2026-02-18T22:58:53.000Z","date":"2026-02-14","kind":"exercise","planned":false,"acquired":true,"shares":1058,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":37906,"source":{"system":"sec-edgar","filing":"0001225208-26-002136","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002136/doc4.xml","form_type":"4"}},{"id":898685,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2026-02-18T22:58:53.000Z","date":"2026-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":788,"price":74.73,"value":58887.24,"ownership":{"direct":true},"balance_after":36848,"source":{"system":"sec-edgar","filing":"0001225208-26-002136","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002136/doc4.xml","form_type":"4"}},{"id":898684,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2026-02-18T22:58:53.000Z","date":"2026-02-13","kind":"exercise","planned":false,"acquired":true,"shares":1766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":37636,"source":{"system":"sec-edgar","filing":"0001225208-26-002136","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002136/doc4.xml","form_type":"4"}},{"id":903212,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-18T00:06:53.000Z","date":"2026-02-12","kind":"grant","planned":false,"acquired":true,"shares":27857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant."}],"balance_after":27857,"derivative":{"exercise_price":74.12,"expiration_date":"2036-02-12","underlying":"Common Stock","underlying_shares":27857},"source":{"system":"sec-edgar","filing":"0001225208-26-002017","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002017/doc4.xml","form_type":"4"}},{"id":903211,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Restricted Stock Units","published_at":"2026-02-18T00:06:53.000Z","date":"2026-02-12","kind":"grant","planned":false,"acquired":true,"shares":11805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant."}],"balance_after":11805,"derivative":{"expiration_date":"2030-02-12","underlying":"Common Stock","underlying_shares":11805},"source":{"system":"sec-edgar","filing":"0001225208-26-002017","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002017/doc4.xml","form_type":"4"}},{"id":903210,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Restricted Stock Units","published_at":"2026-02-18T00:06:53.000Z","date":"2026-02-12","kind":"exercise","planned":false,"acquired":false,"shares":1154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant."}],"balance_after":2308,"derivative":{"expiration_date":"2028-02-12","underlying":"Common Stock","underlying_shares":1154},"source":{"system":"sec-edgar","filing":"0001225208-26-002017","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002017/doc4.xml","form_type":"4"}},{"id":903209,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2026-02-18T00:06:53.000Z","date":"2026-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":573,"price":74.12,"value":42470.76,"ownership":{"direct":true},"balance_after":35870,"source":{"system":"sec-edgar","filing":"0001225208-26-002017","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002017/doc4.xml","form_type":"4"}},{"id":903208,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2026-02-18T00:06:53.000Z","date":"2026-02-12","kind":"exercise","planned":false,"acquired":true,"shares":1154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":36443,"source":{"system":"sec-edgar","filing":"0001225208-26-002017","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002017/doc4.xml","form_type":"4"}},{"id":1076812,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Restricted Stock Units","published_at":"2025-08-04T21:43:43.000Z","date":"2025-08-02","kind":"exercise","planned":false,"acquired":false,"shares":1090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on August 2, 2022, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on August 2, 2022, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"expiration_date":"2025-08-02","underlying":"Common Stock","underlying_shares":1090},"source":{"system":"sec-edgar","filing":"0001225208-25-006988","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825006988/doc4.xml","form_type":"4"}},{"id":1076811,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-08-04T21:43:43.000Z","date":"2025-08-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":528,"price":105.41,"value":55656.48,"ownership":{"direct":true},"balance_after":35289,"source":{"system":"sec-edgar","filing":"0001225208-25-006988","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825006988/doc4.xml","form_type":"4"}},{"id":1076810,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Common Stock","published_at":"2025-08-04T21:43:43.000Z","date":"2025-08-02","kind":"exercise","planned":false,"acquired":true,"shares":1090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":35817,"source":{"system":"sec-edgar","filing":"0001225208-25-006988","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825006988/doc4.xml","form_type":"4"}},{"id":1096630,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-02T20:09:43.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":22173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on July 1, 2026, the first anniversary of the date of grant."}],"balance_after":22173,"derivative":{"exercise_price":104.78,"expiration_date":"2035-07-01","underlying":"Common Stock","underlying_shares":22173},"source":{"system":"sec-edgar","filing":"0001225208-25-006332","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825006332/doc4.xml","form_type":"4"}},{"id":1096629,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"EVP and CFO"}}],"security":"Restricted Stock Units","published_at":"2025-07-02T20:09:43.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":8350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July  1, 2026, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July  1, 2026, the first anniversary of the date of grant."}],"balance_after":8350,"derivative":{"expiration_date":"2029-07-01","underlying":"Common Stock","underlying_shares":8350},"source":{"system":"sec-edgar","filing":"0001225208-25-006332","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825006332/doc4.xml","form_type":"4"}},{"id":1635711,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Deferred Stock Units","published_at":"2024-02-21T02:04:58.000Z","date":"2024-02-18","kind":"exercise","planned":false,"acquired":false,"shares":638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":638},"source":{"system":"sec-edgar","filing":"0001225208-24-002578","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002578/doc4.xml","form_type":"4"}},{"id":1635710,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Restricted Stock Units","published_at":"2024-02-21T02:04:58.000Z","date":"2024-02-17","kind":"exercise","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant."}],"balance_after":1000,"derivative":{"expiration_date":"2025-02-17","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001225208-24-002578","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002578/doc4.xml","form_type":"4"}},{"id":1635709,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Restricted Stock Units","published_at":"2024-02-21T02:04:58.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":false,"shares":990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant."}],"balance_after":1980,"derivative":{"expiration_date":"2026-02-16","underlying":"Common Stock","underlying_shares":990},"source":{"system":"sec-edgar","filing":"0001225208-24-002578","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002578/doc4.xml","form_type":"4"}},{"id":1635708,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2024-02-21T02:04:58.000Z","date":"2024-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":258,"price":65.82,"value":16981.56,"ownership":{"direct":true},"balance_after":37982,"source":{"system":"sec-edgar","filing":"0001225208-24-002578","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002578/doc4.xml","form_type":"4"}},{"id":1635707,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2024-02-21T02:04:58.000Z","date":"2024-02-18","kind":"exercise","planned":false,"acquired":true,"shares":638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock."}],"balance_after":38240,"source":{"system":"sec-edgar","filing":"0001225208-24-002578","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002578/doc4.xml","form_type":"4"}},{"id":1635706,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2024-02-21T02:04:58.000Z","date":"2024-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":404,"price":65.82,"value":26591.28,"ownership":{"direct":true},"balance_after":37602,"source":{"system":"sec-edgar","filing":"0001225208-24-002578","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002578/doc4.xml","form_type":"4"}},{"id":1635705,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2024-02-21T02:04:58.000Z","date":"2024-02-17","kind":"exercise","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":38006,"source":{"system":"sec-edgar","filing":"0001225208-24-002578","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002578/doc4.xml","form_type":"4"}},{"id":1635704,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2024-02-21T02:04:58.000Z","date":"2024-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":427,"price":65.82,"value":28105.14,"ownership":{"direct":true},"balance_after":37006,"source":{"system":"sec-edgar","filing":"0001225208-24-002578","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002578/doc4.xml","form_type":"4"}},{"id":1635703,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2024-02-21T02:04:58.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":true,"shares":990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":37433,"source":{"system":"sec-edgar","filing":"0001225208-24-002578","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002578/doc4.xml","form_type":"4"}},{"id":1639487,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Restricted Stock Units","published_at":"2024-02-16T21:22:15.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":false,"shares":1057,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant."}],"balance_after":3173,"derivative":{"expiration_date":"2027-02-14","underlying":"Common Stock","underlying_shares":1057},"source":{"system":"sec-edgar","filing":"0001225208-24-002307","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002307/doc4.xml","form_type":"4"}},{"id":1639486,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2024-02-16T21:22:15.000Z","date":"2024-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":488,"price":65.95,"value":32183.6,"ownership":{"direct":true},"balance_after":36443,"source":{"system":"sec-edgar","filing":"0001225208-24-002307","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002307/doc4.xml","form_type":"4"}},{"id":1639485,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2024-02-16T21:22:15.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":true,"shares":1057,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":36931,"source":{"system":"sec-edgar","filing":"0001225208-24-002307","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002307/doc4.xml","form_type":"4"}},{"id":1644218,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-14T21:23:06.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":14180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant."}],"balance_after":14180,"derivative":{"exercise_price":64.99,"expiration_date":"2034-02-12","underlying":"Common Stock","underlying_shares":14180},"source":{"system":"sec-edgar","filing":"0001225208-24-002047","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002047/doc4.xml","form_type":"4"}},{"id":1644217,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Restricted Stock Units","published_at":"2024-02-14T21:23:06.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":4616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant."}],"balance_after":4616,"derivative":{"expiration_date":"2028-02-12","underlying":"Common Stock","underlying_shares":4616},"source":{"system":"sec-edgar","filing":"0001225208-24-002047","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002047/doc4.xml","form_type":"4"}},{"id":1724522,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-04T22:42:50.000Z","date":"2023-12-01","kind":"grant","planned":false,"acquired":true,"shares":10543,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in full on December 1, 2026, the third anniversary of the date of grant."}],"balance_after":10543,"derivative":{"exercise_price":56.14,"expiration_date":"2033-12-01","underlying":"Common Stock","underlying_shares":10543},"source":{"system":"sec-edgar","filing":"0001225208-23-010678","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823010678/doc4.xml","form_type":"4"}},{"id":1724521,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Restricted Stock Units","published_at":"2023-12-04T22:42:50.000Z","date":"2023-12-01","kind":"grant","planned":false,"acquired":true,"shares":3562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in full on December 1, 2026, the third anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in full on December 1, 2026, the third anniversary of the date of grant."}],"balance_after":3562,"derivative":{"expiration_date":"2026-12-01","underlying":"Common Stock","underlying_shares":3562},"source":{"system":"sec-edgar","filing":"0001225208-23-010678","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823010678/doc4.xml","form_type":"4"}},{"id":1817052,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Restricted Stock Units","published_at":"2023-08-03T20:23:07.000Z","date":"2023-08-02","kind":"exercise","planned":false,"acquired":false,"shares":1090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on August 2, 2022, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on August 2, 2022, the first anniversary of the date of grant."}],"balance_after":2180,"derivative":{"expiration_date":"2025-08-02","underlying":"Common Stock","underlying_shares":1090},"source":{"system":"sec-edgar","filing":"0001225208-23-007928","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823007928/doc4.xml","form_type":"4"}},{"id":1817051,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2023-08-03T20:23:07.000Z","date":"2023-08-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":487,"price":50.62,"value":24651.94,"ownership":{"direct":true},"balance_after":35874,"source":{"system":"sec-edgar","filing":"0001225208-23-007928","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823007928/doc4.xml","form_type":"4"}},{"id":1817050,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2023-08-03T20:23:07.000Z","date":"2023-08-02","kind":"exercise","planned":false,"acquired":true,"shares":1090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":36361,"source":{"system":"sec-edgar","filing":"0001225208-23-007928","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823007928/doc4.xml","form_type":"4"}},{"id":1840323,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Deferred Stock Units","published_at":"2023-07-03T20:14:48.000Z","date":"2023-07-01","kind":"exercise","planned":false,"acquired":false,"shares":729,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2020, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2020, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"expiration_date":"2023-07-01","underlying":"Common Stock","underlying_shares":729},"source":{"system":"sec-edgar","filing":"0001225208-23-007118","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823007118/doc4.xml","form_type":"4"}},{"id":1840322,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2023-07-03T20:14:48.000Z","date":"2023-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":326,"price":54.09,"value":17633.34,"ownership":{"direct":true},"balance_after":35271,"source":{"system":"sec-edgar","filing":"0001225208-23-007118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823007118/doc4.xml","form_type":"4"}},{"id":1840321,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2023-07-03T20:14:48.000Z","date":"2023-07-01","kind":"exercise","planned":false,"acquired":true,"shares":729,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":35597,"source":{"system":"sec-edgar","filing":"0001225208-23-007118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823007118/doc4.xml","form_type":"4"}},{"id":1934453,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-31T20:30:21.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 30, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant to the reporting person on December 1, 2014, of an option to purchase 17,901 shares of common stock."}],"balance_after":0,"derivative":{"exercise_price":12.89,"expiration_date":"2024-12-01","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001225208-23-004333","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823004333/doc4.xml","form_type":"4"}},{"id":1934452,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2023-03-31T20:30:21.000Z","date":"2023-03-31","kind":"sale","planned":false,"acquired":false,"shares":5000,"price":50,"value":250000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 30, 2022."}],"balance_after":34868,"source":{"system":"sec-edgar","filing":"0001225208-23-004333","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823004333/doc4.xml","form_type":"4"}},{"id":1934451,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2023-03-31T20:30:21.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":12.89,"value":64450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 30, 2022."}],"balance_after":39868,"source":{"system":"sec-edgar","filing":"0001225208-23-004333","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823004333/doc4.xml","form_type":"4"}},{"id":1981461,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-02T21:59:26.000Z","date":"2023-03-01","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant to the reporting person on December 1, 2014, of an option to purchase 17,901 shares of common stock."}],"balance_after":5000,"derivative":{"exercise_price":12.89,"expiration_date":"2024-12-01","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001225208-23-003165","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823003165/doc4.xml","form_type":"4"}},{"id":1981460,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2023-03-02T21:59:26.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":5000,"price":46.663,"value":233315.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $46.488 to $46.78, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":34868,"source":{"system":"sec-edgar","filing":"0001225208-23-003165","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823003165/doc4.xml","form_type":"4"}},{"id":1981459,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2023-03-02T21:59:26.000Z","date":"2023-03-01","kind":"exercise","acquired":true,"shares":5000,"price":12.89,"value":64450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."}],"balance_after":39868,"source":{"system":"sec-edgar","filing":"0001225208-23-003165","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823003165/doc4.xml","form_type":"4"}},{"id":2001492,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Deferred Stock Units","published_at":"2023-02-22T21:55:59.000Z","date":"2023-02-21","kind":"exercise","acquired":false,"shares":623,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"expiration_date":"2023-02-21","underlying":"Common Stock","underlying_shares":623},"source":{"system":"sec-edgar","filing":"0001225208-23-002533","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002533/doc4.xml","form_type":"4"}},{"id":2001491,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2023-02-22T21:55:59.000Z","date":"2023-02-21","kind":"tax_withholding","acquired":false,"shares":252,"price":46.23,"value":11649.96,"ownership":{"direct":true},"balance_after":34868,"source":{"system":"sec-edgar","filing":"0001225208-23-002533","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002533/doc4.xml","form_type":"4"}},{"id":2001490,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2023-02-22T21:55:59.000Z","date":"2023-02-21","kind":"exercise","acquired":true,"shares":623,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":35120,"source":{"system":"sec-edgar","filing":"0001225208-23-002533","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002533/doc4.xml","form_type":"4"}},{"id":2004937,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Deferred Stock Units","published_at":"2023-02-21T21:19:56.000Z","date":"2023-02-18","kind":"exercise","acquired":false,"shares":637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant."}],"balance_after":638,"derivative":{"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":637},"source":{"system":"sec-edgar","filing":"0001225208-23-002380","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002380/doc4.xml","form_type":"4"}},{"id":2004936,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Restricted Stock Units","published_at":"2023-02-21T21:19:56.000Z","date":"2023-02-17","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant."}],"balance_after":2000,"derivative":{"expiration_date":"2025-02-17","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001225208-23-002380","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002380/doc4.xml","form_type":"4"}},{"id":2004935,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Restricted Stock Units","published_at":"2023-02-21T21:19:56.000Z","date":"2023-02-16","kind":"exercise","acquired":false,"shares":990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant."}],"balance_after":2970,"derivative":{"expiration_date":"2026-02-16","underlying":"Common Stock","underlying_shares":990},"source":{"system":"sec-edgar","filing":"0001225208-23-002380","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002380/doc4.xml","form_type":"4"}},{"id":2004934,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2023-02-21T21:19:56.000Z","date":"2023-02-18","kind":"tax_withholding","acquired":false,"shares":254,"price":46.54,"value":11821.16,"ownership":{"direct":true},"balance_after":34497,"source":{"system":"sec-edgar","filing":"0001225208-23-002380","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002380/doc4.xml","form_type":"4"}},{"id":2004933,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2023-02-21T21:19:56.000Z","date":"2023-02-18","kind":"exercise","acquired":true,"shares":637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock."}],"balance_after":34751,"source":{"system":"sec-edgar","filing":"0001225208-23-002380","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002380/doc4.xml","form_type":"4"}},{"id":2004932,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2023-02-21T21:19:56.000Z","date":"2023-02-17","kind":"tax_withholding","acquired":false,"shares":421,"price":46.54,"value":19593.34,"ownership":{"direct":true},"balance_after":34114,"source":{"system":"sec-edgar","filing":"0001225208-23-002380","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002380/doc4.xml","form_type":"4"}},{"id":2004931,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2023-02-21T21:19:56.000Z","date":"2023-02-17","kind":"exercise","acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":34535,"source":{"system":"sec-edgar","filing":"0001225208-23-002380","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002380/doc4.xml","form_type":"4"}},{"id":2004930,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2023-02-21T21:19:56.000Z","date":"2023-02-16","kind":"tax_withholding","acquired":false,"shares":456,"price":46.48,"value":21194.88,"ownership":{"direct":true},"balance_after":33535,"source":{"system":"sec-edgar","filing":"0001225208-23-002380","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002380/doc4.xml","form_type":"4"}},{"id":2004929,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2023-02-21T21:19:56.000Z","date":"2023-02-16","kind":"exercise","acquired":true,"shares":990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":33991,"source":{"system":"sec-edgar","filing":"0001225208-23-002380","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002380/doc4.xml","form_type":"4"}},{"id":2012146,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Deferred Stock Units","published_at":"2023-02-17T00:17:23.000Z","date":"2023-02-15","kind":"exercise","acquired":false,"shares":739,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"expiration_date":"2023-02-15","underlying":"Common Stock","underlying_shares":739},"source":{"system":"sec-edgar","filing":"0001225208-23-002155","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002155/doc4.xml","form_type":"4"}},{"id":2012145,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2023-02-17T00:17:23.000Z","date":"2023-02-15","kind":"tax_withholding","acquired":false,"shares":340,"price":47.29,"value":16078.6,"ownership":{"direct":true},"balance_after":33001,"source":{"system":"sec-edgar","filing":"0001225208-23-002155","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002155/doc4.xml","form_type":"4"}},{"id":2012144,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2023-02-17T00:17:23.000Z","date":"2023-02-15","kind":"exercise","acquired":true,"shares":739,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":33341,"source":{"system":"sec-edgar","filing":"0001225208-23-002155","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002155/doc4.xml","form_type":"4"}},{"id":2014324,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-15T22:45:17.000Z","date":"2023-02-14","kind":"grant","acquired":true,"shares":12702,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant."}],"balance_after":12702,"derivative":{"exercise_price":47.28,"expiration_date":"2033-02-14","underlying":"Common Stock","underlying_shares":12702},"source":{"system":"sec-edgar","filing":"0001225208-23-002039","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002039/doc4.xml","form_type":"4"}},{"id":2014323,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Restricted Stock Units","published_at":"2023-02-15T22:45:17.000Z","date":"2023-02-14","kind":"grant","acquired":true,"shares":4230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant."}],"balance_after":4230,"derivative":{"expiration_date":"2027-02-14","underlying":"Common Stock","underlying_shares":4230},"source":{"system":"sec-edgar","filing":"0001225208-23-002039","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520823002039/doc4.xml","form_type":"4"}},{"id":2196532,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Restricted Stock Units","published_at":"2022-08-03T20:28:45.000Z","date":"2022-08-02","kind":"exercise","acquired":false,"shares":1089,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on August 2, 2022, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on August 2, 2022, the first anniversary of the date of grant."}],"balance_after":3270,"derivative":{"expiration_date":"2025-08-02","underlying":"Common Stock","underlying_shares":1089},"source":{"system":"sec-edgar","filing":"0001225208-22-009191","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822009191/doc4.xml","form_type":"4"}},{"id":2196531,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2022-08-03T20:28:45.000Z","date":"2022-08-02","kind":"tax_withholding","acquired":false,"shares":320,"price":41.46,"value":13267.2,"ownership":{"direct":true},"balance_after":32602,"source":{"system":"sec-edgar","filing":"0001225208-22-009191","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822009191/doc4.xml","form_type":"4"}},{"id":2196530,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2022-08-03T20:28:45.000Z","date":"2022-08-02","kind":"exercise","acquired":true,"shares":1089,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":32922,"source":{"system":"sec-edgar","filing":"0001225208-22-009191","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822009191/doc4.xml","form_type":"4"}},{"id":2213144,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Deferred Stock Units","published_at":"2022-07-06T20:56:41.000Z","date":"2022-07-01","kind":"exercise","acquired":false,"shares":728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2020, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2020, the first anniversary of the date of grant."}],"balance_after":729,"derivative":{"expiration_date":"2023-07-01","underlying":"Common Stock","underlying_shares":728},"source":{"system":"sec-edgar","filing":"0001225208-22-008662","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822008662/doc4.xml","form_type":"4"}},{"id":2213143,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2022-07-06T20:56:41.000Z","date":"2022-07-01","kind":"tax_withholding","acquired":false,"shares":214,"price":38.01,"value":8134.14,"ownership":{"direct":true},"balance_after":31833,"source":{"system":"sec-edgar","filing":"0001225208-22-008662","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822008662/doc4.xml","form_type":"4"}},{"id":2213142,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"SVP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2022-07-06T20:56:41.000Z","date":"2022-07-01","kind":"exercise","acquired":true,"shares":728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":32047,"source":{"system":"sec-edgar","filing":"0001225208-22-008662","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822008662/doc4.xml","form_type":"4"}},{"id":2362760,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"VP, Global Controller and CAO"}}],"security":"Deferred Stock Units","published_at":"2022-03-02T21:28:44.000Z","date":"2022-02-28","kind":"exercise","acquired":false,"shares":815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"expiration_date":"2022-02-28","underlying":"Common Stock","underlying_shares":815},"source":{"system":"sec-edgar","filing":"0001225208-22-003864","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822003864/doc4.xml","form_type":"4"}},{"id":2362759,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"VP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2022-03-02T21:28:44.000Z","date":"2022-02-28","kind":"tax_withholding","acquired":false,"shares":238,"price":44.17,"value":10512.46,"ownership":{"direct":true},"balance_after":31319,"source":{"system":"sec-edgar","filing":"0001225208-22-003864","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822003864/doc4.xml","form_type":"4"}},{"id":2362758,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"VP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2022-03-02T21:28:44.000Z","date":"2022-02-28","kind":"exercise","acquired":true,"shares":815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":31557,"source":{"system":"sec-edgar","filing":"0001225208-22-003864","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822003864/doc4.xml","form_type":"4"}},{"id":2380086,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"VP, Global Controller and CAO"}}],"security":"Deferred Stock Units","published_at":"2022-02-23T21:17:34.000Z","date":"2022-02-21","kind":"exercise","acquired":false,"shares":623,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant."}],"balance_after":623,"derivative":{"expiration_date":"2023-02-21","underlying":"Common Stock","underlying_shares":623},"source":{"system":"sec-edgar","filing":"0001225208-22-003083","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822003083/doc4.xml","form_type":"4"}},{"id":2380085,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"VP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2022-02-23T21:17:34.000Z","date":"2022-02-21","kind":"tax_withholding","acquired":false,"shares":180,"price":42.55,"value":7659.0,"ownership":{"direct":true},"balance_after":30742,"source":{"system":"sec-edgar","filing":"0001225208-22-003083","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822003083/doc4.xml","form_type":"4"}},{"id":2380084,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"VP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2022-02-23T21:17:34.000Z","date":"2022-02-21","kind":"exercise","acquired":true,"shares":623,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":30922,"source":{"system":"sec-edgar","filing":"0001225208-22-003083","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822003083/doc4.xml","form_type":"4"}},{"id":2383553,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"VP, Global Controller and CAO"}}],"security":"Deferred Stock Units","published_at":"2022-02-22T21:46:03.000Z","date":"2022-02-18","kind":"exercise","acquired":false,"shares":637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant."}],"balance_after":1275,"derivative":{"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":637},"source":{"system":"sec-edgar","filing":"0001225208-22-002923","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822002923/doc4.xml","form_type":"4"}},{"id":2383552,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"VP, Global Controller and CAO"}}],"security":"Restricted Stock Units","published_at":"2022-02-22T21:46:03.000Z","date":"2022-02-17","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant."}],"balance_after":3000,"derivative":{"expiration_date":"2025-02-17","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001225208-22-002923","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822002923/doc4.xml","form_type":"4"}},{"id":2383551,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"VP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2022-02-22T21:46:03.000Z","date":"2022-02-18","kind":"tax_withholding","acquired":false,"shares":210,"price":42.55,"value":8935.5,"ownership":{"direct":true},"balance_after":30299,"source":{"system":"sec-edgar","filing":"0001225208-22-002923","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822002923/doc4.xml","form_type":"4"}},{"id":2383550,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"VP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2022-02-22T21:46:03.000Z","date":"2022-02-18","kind":"exercise","acquired":true,"shares":637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":30509,"source":{"system":"sec-edgar","filing":"0001225208-22-002923","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822002923/doc4.xml","form_type":"4"}},{"id":2383549,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"VP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2022-02-22T21:46:03.000Z","date":"2022-02-17","kind":"tax_withholding","acquired":false,"shares":350,"price":42.83,"value":14990.5,"ownership":{"direct":true},"balance_after":29872,"source":{"system":"sec-edgar","filing":"0001225208-22-002923","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822002923/doc4.xml","form_type":"4"}},{"id":2383548,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"VP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2022-02-22T21:46:03.000Z","date":"2022-02-17","kind":"exercise","acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":30222,"source":{"system":"sec-edgar","filing":"0001225208-22-002923","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822002923/doc4.xml","form_type":"4"}},{"id":2389874,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"VP, Global Controller and CAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-18T01:25:26.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":13180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant."}],"balance_after":13180,"derivative":{"exercise_price":44.19,"expiration_date":"2032-02-16","underlying":"Common Stock","underlying_shares":13180},"source":{"system":"sec-edgar","filing":"0001225208-22-002679","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822002679/doc4.xml","form_type":"4"}},{"id":2389873,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"VP, Global Controller and CAO"}}],"security":"Restricted Stock Units","published_at":"2022-02-18T01:25:26.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":3960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant."}],"balance_after":3960,"derivative":{"expiration_date":"2026-02-16","underlying":"Common Stock","underlying_shares":3960},"source":{"system":"sec-edgar","filing":"0001225208-22-002679","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822002679/doc4.xml","form_type":"4"}},{"id":2389872,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"VP, Global Controller and CAO"}}],"security":"Deferred Stock Units","published_at":"2022-02-18T01:25:26.000Z","date":"2022-02-15","kind":"exercise","acquired":false,"shares":738,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant."}],"balance_after":739,"derivative":{"expiration_date":"2023-02-15","underlying":"Common Stock","underlying_shares":738},"source":{"system":"sec-edgar","filing":"0001225208-22-002679","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822002679/doc4.xml","form_type":"4"}},{"id":2389871,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"VP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2022-02-18T01:25:26.000Z","date":"2022-02-15","kind":"tax_withholding","acquired":false,"shares":259,"price":44.01,"value":11398.59,"ownership":{"direct":true},"balance_after":29222,"source":{"system":"sec-edgar","filing":"0001225208-22-002679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822002679/doc4.xml","form_type":"4"}},{"id":2389870,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"VP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2022-02-18T01:25:26.000Z","date":"2022-02-15","kind":"exercise","acquired":true,"shares":738,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":29481,"source":{"system":"sec-edgar","filing":"0001225208-22-002679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520822002679/doc4.xml","form_type":"4"}},{"id":2615985,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"VP, Global Controller and CAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-04T20:37:21.000Z","date":"2021-08-02","kind":"grant","acquired":true,"shares":15503,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on August 2, 2022, the first anniversary of the date of grant."}],"balance_after":15503,"derivative":{"exercise_price":45.88,"expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":15503},"source":{"system":"sec-edgar","filing":"0001225208-21-011120","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520821011120/doc4.xml","form_type":"4"}},{"id":2615984,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"VP, Global Controller and CAO"}}],"security":"Restricted Stock Units","published_at":"2021-08-04T20:37:21.000Z","date":"2021-08-02","kind":"grant","acquired":true,"shares":4359,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on August 2, 2022, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on August 2, 2022, the first anniversary of the date of grant."}],"balance_after":4359,"derivative":{"expiration_date":"2025-08-02","underlying":"Common Stock","underlying_shares":4359},"source":{"system":"sec-edgar","filing":"0001225208-21-011120","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520821011120/doc4.xml","form_type":"4"}},{"id":2642490,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"VP, Global Controller and CAO"}}],"security":"Deferred Stock Units","published_at":"2021-07-06T20:10:06.000Z","date":"2021-07-01","kind":"exercise","acquired":false,"shares":728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2020, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2020, the first anniversary of the date of grant."}],"balance_after":1457,"derivative":{"expiration_date":"2023-07-01","underlying":"Common Stock","underlying_shares":728},"source":{"system":"sec-edgar","filing":"0001225208-21-010273","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520821010273/doc4.xml","form_type":"4"}},{"id":2642489,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"VP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2021-07-06T20:10:06.000Z","date":"2021-07-01","kind":"tax_withholding","acquired":false,"shares":214,"price":43.36,"value":9279.04,"ownership":{"direct":true},"balance_after":28743,"source":{"system":"sec-edgar","filing":"0001225208-21-010273","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520821010273/doc4.xml","form_type":"4"}},{"id":2642488,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"VP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2021-07-06T20:10:06.000Z","date":"2021-07-01","kind":"exercise","acquired":true,"shares":728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":28957,"source":{"system":"sec-edgar","filing":"0001225208-21-010273","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520821010273/doc4.xml","form_type":"4"}},{"id":2664931,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"VP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2021-06-17T20:14:41.000Z","date":"2021-06-16","kind":"sale","acquired":false,"shares":8833,"price":42.764,"value":377734.412,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $42.66 to $42.84, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":28229,"source":{"system":"sec-edgar","filing":"0001225208-21-009506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520821009506/doc4.xml","form_type":"4"}},{"id":2667077,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"VP, Global Controller and CAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-16T20:22:30.000Z","date":"2021-06-15","kind":"exercise","acquired":false,"shares":7901,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant to the reporting person on December 1, 2014, of an option to purchase 17,901 shares of common stock."}],"balance_after":10000,"derivative":{"exercise_price":12.89,"expiration_date":"2024-12-01","underlying":"Common Stock","underlying_shares":7901},"source":{"system":"sec-edgar","filing":"0001225208-21-009468","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520821009468/doc4.xml","form_type":"4"}},{"id":2667076,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"VP, Global Controller and CAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-16T20:22:30.000Z","date":"2021-06-14","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant to the reporting person on February 24, 2014, of an option to purchase 15,000 shares of common stock."}],"balance_after":0,"derivative":{"exercise_price":13.08,"expiration_date":"2024-02-24","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001225208-21-009468","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520821009468/doc4.xml","form_type":"4"}},{"id":2667075,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":24808,"kind":"person","name":"Monson Jonathan","position":1,"cik":"0001779170","reported_name":"Monson Jonathan","relationship":{"officer":true,"officer_title":"VP, Global Controller and CAO"}}],"security":"Common Stock","published_at":"2021-06-16T20:22:30.000Z","date":"2021-06-15","kind":"sale","acquired":false,"shares":7901,"price":42.7842,"value":338037.9642,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $42.63 to $42.93, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":37062,"source":{"system":"sec-edgar","filing":"0001225208-21-009468","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520821009468/doc4.xml","form_type":"4"}}],"next_cursor":"2021-06-16T20:22:30.000000Z,2667075"}